{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T19:55:44Z","timestamp":1784145344355,"version":"3.55.0"},"reference-count":43,"publisher":"CSIRO Publishing","issue":"1","license":[{"start":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T00:00:00Z","timestamp":1755388800000},"content-version":"vor","delay-in-days":2071,"URL":"https:\/\/doi.org\/10.1071\/journalslicense"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neisseria gonorrhoeae has developed resistance to various antimicrobials. At least 10 countries have reported treatment failures with extended-spectrum cephalosporins. Periodic surveillance is essential to determine local treatment guidelines. This study was conducted to determine the resistance of N. gonorrhoeae to penicillin, tetracycline, levofloxacin, cefixime and ceftriaxone among the high-risk population for acquiring STIs in Jakarta and to identify factors associated with resistance. Methods: A cross-sectional study was conducted in Jakarta, Indonesia, from September to November 2018. In all, 98 high-risk males and females who fulfilled the study criteria were included. Specimens were collected from urethral or endocervical swabs, put into Amies transport medium and then transported to the Laboratory of Clinical Microbiology, Universitas Indonesia for culture and identification. Proven gonococcal isolates were examined for susceptibility to various antimicrobials using the disk diffusion method according to Clinical and Laboratory Standard Institute guidelines. Results: Of the 98 specimens, 35 were confirmed to be N. gonorrhoeae. The proportion of N. gonorrhoeae specimens resistant to penicillin, tetracycline, levofloxacin, cefixime and ceftriaxone among the high-risk population was 97.1%, 97.1%, 34.3%, 0% and 0% respectively. The possible factors associated with resistance could only be analysed for levofloxacin. Age, sexual orientation and a history of orogenital sexual activity during the past month were not associated with N. gonorrhoeae resistance to levofloxacin. Conclusion: This study detected no resistance of N. gonorrhoeae to cefixime and ceftriaxone. Further studies with larger samples are needed to obtain more representative results of N. gonorrhoeae resistance and the possible factors associated with resistance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1071\/sh19140","type":"journal-article","created":{"date-parts":[[2019,12,15]],"date-time":"2019-12-15T18:57:50Z","timestamp":1576436270000},"page":"9-14","source":"Crossref","is-referenced-by-count":4,"title":["Antimicrobial resistance of Neisseria gonorrhoeae in Jakarta, Indonesia: a cross-sectional study"],"prefix":"10.1071","volume":"17","author":[{"given":"Wresti","family":"Indriatmi","sequence":"first","affiliation":[{"name":"ADepartment of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia, Jalan Pangeran Diponegoro No. 71, RW 05, Kelurahan Kenari, Kecamatan Senen, Kota Jakarta Pusat, 10430, DKI Jakarta."},{"name":"BDr Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia, Jalan Pangeran Diponegoro No. 71, RW 05, Kelurahan Kenari, Kecamatan Senen, Kota Jakarta Pusat, 10430, DKI Jakarta."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7516-710X","authenticated-orcid":true,"given":"Rizky Lendl","family":"Prayogo","sequence":"additional","affiliation":[{"name":"ADepartment of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia, Jalan Pangeran Diponegoro No. 71, RW 05, Kelurahan Kenari, Kecamatan Senen, Kota Jakarta Pusat, 10430, DKI Jakarta."},{"name":"BDr Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia, Jalan Pangeran Diponegoro No. 71, RW 05, Kelurahan Kenari, Kecamatan Senen, Kota Jakarta Pusat, 10430, DKI Jakarta."},{"name":"CCorresponding author. Email: rlendlprayogo@gmail.com"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanny","family":"Nilasari","sequence":"additional","affiliation":[{"name":"ADepartment of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia, Jalan Pangeran Diponegoro No. 71, RW 05, Kelurahan Kenari, Kecamatan Senen, Kota Jakarta Pusat, 10430, DKI Jakarta."},{"name":"BDr Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia, Jalan Pangeran Diponegoro No. 71, RW 05, Kelurahan Kenari, Kecamatan Senen, Kota Jakarta Pusat, 10430, DKI Jakarta."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lis Surachmiati","family":"Suseno","sequence":"additional","affiliation":[{"name":"ADepartment of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia, Jalan Pangeran Diponegoro No. 71, RW 05, Kelurahan Kenari, Kecamatan Senen, Kota Jakarta Pusat, 10430, DKI Jakarta."},{"name":"BDr Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia, Jalan Pangeran Diponegoro No. 71, RW 05, Kelurahan Kenari, Kecamatan Senen, Kota Jakarta Pusat, 10430, DKI Jakarta."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"67","published-online":{"date-parts":[[2019,12,16]]},"reference":[{"key":"2025102615481887100_R1"},{"key":"2025102615481887100_R2"},{"key":"2025102615481887100_R3"},{"key":"2025102615481887100_R4"},{"key":"2025102615481887100_R5"},{"key":"2025102615481887100_R6"},{"key":"2025102615481887100_R7"},{"key":"2025102615481887100_R8"},{"key":"2025102615481887100_R9","first-page":"147","article-title":"Prevalensi infeksi menular seksual dan aspek sosial pada WPS dalam rehabilitasi di Panti Sosial Karya Wanita Mulya Jaya Departemen Sosial Pasar Rebo Jakarta.","volume":"41","author":"Nilasari","year":"2014","journal-title":"MDVI"},{"key":"2025102615481887100_R10"},{"key":"2025102615481887100_R11"},{"key":"2025102615481887100_R12"},{"key":"2025102615481887100_R13"},{"key":"2025102615481887100_R14"},{"key":"2025102615481887100_R15"},{"key":"2025102615481887100_R16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/microbiolspec.EI10-0009-2015","article-title":"Antimicrobial resistance expressed by Neisseria gonorrhoeae: a major global public health problem in the 21st century.","volume":"4","author":"Unemo","year":"2016","journal-title":"Microbiol Spectr"},{"key":"2025102615481887100_R17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3390\/tropicalmed2030045","article-title":"Antibiotic susceptibility monitoring of Neisseria gonorrhoeae in Bacolod City, Philippines.","volume":"2","author":"Araneta","year":"2017","journal-title":"Trop Med Infect Dis"},{"key":"2025102615481887100_R18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.7883\/yoken.JJID.2017.169","article-title":"Surveillanve of antimicrobial susceptibilities of Neisseria gonorrhoeae from 2013 to 2015 in Guangxi Province, China.","volume":"71","author":"Li","year":"2018","journal-title":"Jpn J Infect Dis"},{"key":"2025102615481887100_R19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jgar.2017.12.001","article-title":"Antibiotic susceptibility of Neisseria gonorrhoeae in Vientiane, Lao PDR.","volume":"13","author":"Phouangsouvanh","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"2025102615481887100_R20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4103\/ijmm.IJMM_18_123","article-title":"Alarming resistance of Neisseria gonorrhoeae in a tertiary care hospital of North India.","volume":"36","author":"Sharma","year":"2018","journal-title":"Indian J Med Microbiol"},{"key":"2025102615481887100_R21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.7883\/yoken.JJID.2016.209","article-title":"Gonococcal antimicrobial susceptibility and the prevalence of blaTEM-1 and blaTEM-135 genes in Neisseria gonorrhoeae isolates from Thailand.","volume":"70","author":"Tribuddharat","year":"2017","journal-title":"Jpn J Infect Dis"},{"key":"2025102615481887100_R22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201721","article-title":"Antibiotic resistance in Neisseria gonorrhoea and treatment outcomes of gonococcal urethritis suspected patients in two large hospitals in Bhutan, 2015","volume":"13","author":"Tshokey","year":"2018","journal-title":"PLoS One"},{"key":"2025102615481887100_R23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.diagmicrobio.2018.06.004","article-title":"Determining the in vitro susceptibility of Neisseria gonorrhoeae isolates from 8 cities in Guangdong Province through an improved microdilution method.","volume":"92","author":"Wu","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2025102615481887100_R24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/sextrans-2017-053340","article-title":"Antimicrobial susceptibility profile of Neisseria gonorrhoeae isolated in Cotonou, Benin (2015\u20132017).","volume":"94","author":"Affolabi","year":"2018","journal-title":"Sex Transm Infect"},{"key":"2025102615481887100_R25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s13104-016-2247-4","article-title":"Neisseria gonorrhoeae among suspects of sexually transmitted infection in Gambella Hospital, Ethiopia: risk factors and drug resistance.","volume":"9","author":"Ali","year":"2016","journal-title":"BMC Res Notes"},{"key":"2025102615481887100_R26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/0956462418799017","article-title":"Complete ciprofloxacin resistance in gonococcal isolates in an urban Ugandan clinic: findings from a cross-sectional study.","volume":"30","author":"Mabonga","year":"2019","journal-title":"Int J STD AIDS"},{"key":"2025102615481887100_R27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/OLQ.0000000000000943","article-title":"Establishment of a Gonococcal Antimicrobial Surveillance Programme, in accordance with World Health Organization standards, in C\u00f4te d\u2019Ivoire, Western Africa, 2014\u20132017.","volume":"46","author":"Y\u00e9o","year":"2019","journal-title":"Sex Transm Dis"},{"key":"2025102615481887100_R28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13756-018-0376-3","article-title":"Neisseria gonorrhoae and their antimicrobial susceptibility patterns among symptomatic patients from Gondar town, north West Ethiopia.","volume":"7","author":"Yeshanew","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"key":"2025102615481887100_R29","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1093\/jac\/dky090","article-title":"First nationwide antimicrobial susceptibility surveillance for Neisseria gonorrhoeae in Brazil, 2015\u201316.","volume":"73","author":"Bazzo","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2025102615481887100_R30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/jac\/dkx405","article-title":"Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand.","volume":"73","author":"Lee","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2025102615481887100_R31","first-page":"71","article-title":"Keeping track of antimicrobial resistance for Neisseria gonorrhoeae in Auckland, New Zealand: past, present and future considerations.","volume":"131","author":"McAuliffe","year":"2018","journal-title":"N Z Med J"},{"key":"2025102615481887100_R32"},{"key":"2025102615481887100_R33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/OLQ.0000000000000556","article-title":"Antimicrobial susceptibility of Neisseria gonorrhoeae in Japan from 2000 to 2015.","volume":"44","author":"Yasuda","year":"2017","journal-title":"Sex Transm Dis"},{"key":"2025102615481887100_R34","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/OLQ.0000000000000510","article-title":"Gonorrhea in Indonesia: high prevalence of asymptomatic urogenital gonorrhea but no circulating extended spectrum cephalosporins-resistant Neisseria gonorrhoeae strains in Jakarta, Yogyakarta, and Denpasar, Indonesia.","volume":"43","author":"Hananta","year":"2016","journal-title":"Sex Transm Dis"},{"key":"2025102615481887100_R35"},{"key":"2025102615481887100_R36","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/OLQ.0000000000000185","article-title":"Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in Europe.","volume":"41","author":"Cole","year":"2014","journal-title":"Sex Transm Dis"},{"key":"2025102615481887100_R37","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3201\/eid1808.111202","article-title":"Factors related to increasing prevalence of resistance to ciprofloxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United States.","volume":"18","author":"Goldstein","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"2025102615481887100_R38"},{"key":"2025102615481887100_R39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10156-002-0204-8","article-title":"Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval.","volume":"9","author":"Deguchi","year":"2003","journal-title":"J Infect Chemother"},{"key":"2025102615481887100_R40","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3201\/eid1308.060948","article-title":"Threat to cefixime treatment for gonorrhea.","volume":"13","author":"Yokoi","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"2025102615481887100_R41","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1586\/eri.09.63","article-title":"Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae.","volume":"7","author":"Tapsall","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2025102615481887100_R42","doi-asserted-by":"publisher","first-page":"19721","DOI":"10.2807\/ese.15.47.19721-en","article-title":"Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010.","volume":"15","author":"Unemo","year":"2010","journal-title":"Euro Surveill"},{"key":"2025102615481887100_R43","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1517\/14656560902731993","article-title":"The use of cephalosporins for gonorrhea: the impending problem of resistance.","volume":"10","author":"Barry","year":"2009","journal-title":"Expert Opin Pharmacother"}],"container-title":["Sexual Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/17\/1\/9\/756065\/sh19140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/17\/1\/9\/756065\/sh19140.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:48:29Z","timestamp":1761508109000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/sh\/article\/17\/1\/9\/92891\/Antimicrobial-resistance-of-Neisseria-gonorrhoeae"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,16]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2,5]]}},"URL":"https:\/\/doi.org\/10.1071\/sh19140","relation":{},"ISSN":["1448-5028","1449-8987"],"issn-type":[{"value":"1448-5028","type":"print"},{"value":"1449-8987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,16]]}}}